European National Health Service Chooses Kneat’s eValidation Platform

LIMERICK, Ireland, March 18, 2022 /CNW/ –, inc. (TSX: KSI) (“Kneat” Where “the company”), leader in the digitization and automation of validation and quality processes, is pleased to announce that it has signed a framework services agreement with a European national health service.

The health system in this country has more than 110,000 employees spread across more than 15 health boards and organizations. After a thorough evaluation process, while navigating the challenges of the Covid-19 pandemic, they chose Kneat as their enterprise solution for laboratory equipment validation lifecycle management. They plan to roll out Kneat to five labs in their blood transfusion services in 2022.

The agreement is effective immediately and allows the organization to expand Kneat to all of its regional councils, providing a significant expansion opportunity for Kneat. Implementation will begin immediately, with an expected go-live date in Q3 2022.

“We are delighted that this leading national health service entrusts Kneat with supporting the delivery of high quality care to its patients,” commented Eddie Ryan, CEO of Knee. “Kneat has demonstrated product leadership and continues to be the preferred supplier to the life sciences industry,” continued Ryan.

With the addition of this national healthcare customer, Kneat further demonstrates its applicability to many life science segments.

About Knee

Kneat, a Canadian company with operational headquarters in Limerick, Ireland, develops and markets the new generation Kneat Gx software platform. Several business work processes can be configured on the platform, from equipment validation to IT system validation to quality document management. Kneat’s software allows users to create, review, approve, run online tests, manage all exceptions, and post-approve final deliverables in a controlled platform that is FDA 21 CFR Part 11/Eudralex Annex 11 compliant. Macro and micro reporting dashboards allow powerful monitoring of all systems, projects and processes globally. Customer case studies report productivity improvements greater than 100% and a higher standard of data integrity and compliance. For more information, visit

Cautionary and forward-looking statements

Except for statements of historical fact contained herein, certain information presented constitutes “forward-looking information” within the meaning of applicable Canadian securities laws. Such forward-looking information includes, but is not limited to, the relationship between Kneat and the customer, Kneat’s business development activities, timelines for the use and implementation of Kneat’s software as part of the validation processes of the Customer, Customer’s ability and intent to evolve Kneat’s software usage within Customer’s organization, and Kneat’s platform compliance through audit and regulatory inspections. Although these forward-looking statements are made by Kneat, as set forth in this release, in good faith and believed by Kneat to have a reasonable basis, they are subject to significant risks and uncertainties. Due to these risks and uncertainties, the events predicted in these forward-looking statements may differ materially from actual results or events. These forward-looking statements are not guarantees of future performance, as they involve risks and uncertainties. The forward-looking information contained in this press release does not include a full assessment or consideration of the unprecedented impacts of the COVID-19 pandemic occurring since the first quarter of 2020 and the ongoing and developing indirect global and regional economic impacts that result. This has resulted in significant economic uncertainty and while the company has not experienced any material impact to its operations thus far, any potential impact on our future is difficult to understand or measure at this time. Kneat undertakes no obligation to release revisions to any forward-looking statements, except as may be required under applicable securities laws. Investors should not assume that any failure to update a previously issued forward-looking statement constitutes a restatement of such statement. Any continued reliance on forward-looking statements is at the investors’ own risk.

SOURCE, inc.

For more information: Hugh Kavanagh, Chief Financial Officer, P: +353 61 203826, E: [email protected]; James Bowen, Knee Investor Relations, T: +1 416-519-9442, E: [email protected]

Previous P&O Ferries lays off 800 sailors and halts crossings "for the next few days"
Next Covid News: NYC reports spread of Omicron version BA.2